BARBARO, MARIA RAFFAELLA
 Distribuzione geografica
Continente #
AS - Asia 3.479
NA - Nord America 3.397
EU - Europa 3.077
AF - Africa 302
SA - Sud America 198
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.474
Nazione #
US - Stati Uniti d'America 3.330
IT - Italia 1.565
SG - Singapore 935
CN - Cina 852
VN - Vietnam 785
GB - Regno Unito 326
HK - Hong Kong 324
DE - Germania 242
SE - Svezia 205
IN - India 159
BR - Brasile 143
FR - Francia 142
NL - Olanda 123
KR - Corea 105
RU - Federazione Russa 105
IE - Irlanda 75
TG - Togo 74
BD - Bangladesh 73
CI - Costa d'Avorio 73
FI - Finlandia 60
ZA - Sudafrica 59
JP - Giappone 57
CH - Svizzera 38
CA - Canada 32
BE - Belgio 28
CD - Congo 27
NG - Nigeria 26
EE - Estonia 24
ID - Indonesia 24
PH - Filippine 24
UA - Ucraina 24
AT - Austria 23
AR - Argentina 22
JO - Giordania 21
SC - Seychelles 21
TH - Thailandia 20
BG - Bulgaria 18
ES - Italia 17
TR - Turchia 17
AU - Australia 16
EC - Ecuador 14
TW - Taiwan 14
IR - Iran 13
MX - Messico 13
AL - Albania 10
PL - Polonia 9
PT - Portogallo 9
CO - Colombia 8
IQ - Iraq 7
PK - Pakistan 7
EG - Egitto 6
CZ - Repubblica Ceca 5
HR - Croazia 5
MY - Malesia 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
CL - Cile 4
DK - Danimarca 4
KZ - Kazakistan 4
LT - Lituania 4
MA - Marocco 4
NP - Nepal 4
NZ - Nuova Zelanda 4
SM - San Marino 4
TT - Trinidad e Tobago 4
HN - Honduras 3
KE - Kenya 3
KG - Kirghizistan 3
LV - Lettonia 3
PY - Paraguay 3
SA - Arabia Saudita 3
YE - Yemen 3
AG - Antigua e Barbuda 2
BB - Barbados 2
BY - Bielorussia 2
CR - Costa Rica 2
GR - Grecia 2
IL - Israele 2
JM - Giamaica 2
NI - Nicaragua 2
OM - Oman 2
RO - Romania 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
Totale 10.465
Città #
Singapore 681
Ashburn 337
Hong Kong 294
Bologna 288
Fairfield 249
Southend 241
Hefei 208
Ho Chi Minh City 204
San Jose 203
Hanoi 181
Santa Clara 150
Chandler 149
Milan 144
Woodbridge 125
Houston 111
Seattle 111
Wilmington 111
Rome 100
Beijing 96
Seoul 96
Cambridge 90
Los Angeles 85
Boardman 83
Lomé 74
Abidjan 73
Brescia 73
Dublin 73
Princeton 70
Ann Arbor 69
New York 64
Frankfurt am Main 60
Council Bluffs 59
Florence 55
Dong Ket 54
Lauterbourg 50
Tokyo 46
Helsinki 38
Nanjing 36
Dallas 35
Munich 35
Naples 33
Da Nang 30
Padova 30
Johannesburg 29
Haiphong 28
Orem 27
Parma 27
Lubumbashi 26
Turin 26
Westminster 26
Berlin 24
Bengaluru 23
Redondo Beach 23
São Paulo 23
Abeokuta 22
Amsterdam 22
Bern 21
Amman 20
Buffalo 20
London 20
San Diego 20
Shanghai 19
Changsha 17
Rimini 17
Brussels 16
Nuremberg 16
Piscataway 16
Atlanta 15
Lappeenranta 15
Pisa 15
Sofia 15
Chicago 14
Denver 14
Guangzhou 14
Hyderabad 14
Jakarta 14
Redmond 14
Vienna 13
Beerse 12
Falls Church 12
Saint Petersburg 12
Modena 11
Secaucus 11
Ardabil 10
Jinan 10
Montreal 10
Nanchang 10
Padua 10
Phoenix 10
Pomigliano d'Arco 10
Poplar 10
The Dalles 10
Thái Nguyên 10
Verona 10
Catania 9
Des Moines 9
Mumbai 9
Pune 9
Ravenna 9
Tirana 9
Totale 6.301
Nome #
METODO E KIT PER LA DIAGNOSI DELLA SENSIBILITA’ AL GLUTINE NON ASSOCIATA ALLA CELIACHIA 410
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 359
5-oxoETE triggers nociception in constipation-predominant irritable bowel syndrome through MAS-related G protein–coupled receptor D 329
Management of Irritable Bowel Syndrome With Diarrhea 316
Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators 314
Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome 277
Lactiplantibacillus plantarum (CECT7484 and CECT7485) and Pedioccoccus acidilactici (CECT7483) enhance actin cytoskeleton and CYP1A1 expression restoring epithelial permeability alterations induced by irritable bowel syndrome mediators 240
Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome 238
Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome 237
Advancements in drug development for diarrhea-predominant irritable bowel syndrome 232
New insights into irritable bowel syndrome pathophysiological mechanisms: contribution of epigenetics 227
Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial 219
Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier 215
Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity 211
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 206
Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor beta2 200
Molecular Mechanisms Underlying Loss of Vascular and Epithelial Integrity in Irritable Bowel Syndrome 198
Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis 198
Pathophysiology of Diverticular Disease: From Diverticula Formation to Symptom Generation 192
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers 192
Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS 191
Diagnostic challenges of symptomatic uncomplicated diverticular disease 191
Non-celiac gluten sensitivity in the context of functional gastrointestinal disorders 190
Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism 182
Post COVID-19 irritable bowel syndrome 181
Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome 181
null 179
Nerve fiber overgrowth in patients with symptomatic diverticular disease 169
The Role of Microbiota in Upper Gastrointestinal Cancers 167
Pathophysiology and Clinical Management of Bile Acid Diarrhea 161
Supernatants of irritable bowel syndrome mucosal biopsies impair human colonic smooth muscle contractility 160
Cytochromes b561: ascorbate-mediated trans-membrane electron transport 158
Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. 158
Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases 156
Consumption of 2 Green Kiwifruits Daily Improves Constipation and Abdominal Comfort - Results of an International Multicenter Randomized Controlled Trial 155
Chronic constipation: from pathophysiology to management 153
Meta-analysis: Post-COVID-19 functional dyspepsia and irritable bowel syndrome 150
Treatment of diverticular disease with aminosalicylates: The evidence 144
Implications of SARS-CoV-2 infection for neurogastroenterology 143
Corrigendum: Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier (Front. Nutr., (2021), 8, (718356), 10.3389/fnut.2021.718356) 142
The role of microbiota and its modulation in colonic diverticular disease 141
Microbiota modulation in disorders of gut-brain interaction 140
Recent advances in understanding non-celiac gluten sensitivity 135
Fecal short-chain fatty acids in non-constipated irritable bowel syndrome: a potential clinically relevant stratification factor based on catabotyping analysis 134
µ-opioid receptor, β-endorphin, and cannabinoid receptor-2 are increased in the colonic mucosa of irritable bowel syndrome patients. 134
Protease-activated receptor 1 is implicated in irritable bowel syndrome mediators-induced signaling to thoracic human sensory neurons 128
Gut microbiota signatures and modulation in irritable bowel syndrome 117
Pre- and probiotic overview 115
AIR12, a b-type cytochrome of the plasma membrane of Arabidopsis thaliana is a negative regulator of resistance against Botrytis cinerea 114
Antibiotic use during gastrointestinal infections increases the risk of developing irritable bowel syndrome: a Systematic Review and Meta-Analysis 101
null 101
Impact of the Trophic Effects of the Secretome from a Multistrain Probiotic Preparation on the Intestinal Epithelia 96
Role of inflammation in pediatric irritable bowel syndrome 92
Digestive symptoms in daily life of chronic adrenal insufficiency patients are similar to irritable bowel syndrome symptoms 88
Letter: Post-COVID-19 disorders of gut–brain interaction (DGBI)—just post-infectious or a multifaceted entity? Authors' reply 86
Italian nationwide survey of pharmacologic treatments in diverticular disease: Results from the REMAD registry 86
Long-Term Impact of COVID-19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities 83
A Probiotic Mixture of Lactobacillus rhamnosus LR 32, Bifidobacterium lactis BL 04, and Bifidobacterium longum BB 536 Counteracts the Increase in Permeability Induced by the Mucosal Mediators of Irritable Bowel Syndrome by Acting on Zonula Occludens 1 83
null 81
Functional Foods and Nutraceuticals in Irritable Bowel Syndrome 77
Letter: Post-COVID-19 functional dyspepsia and irritable bowel syndrome—Authors' reply 68
Multistrain Probiotics Plus Vitamin D Improve Gut Barrier Function and Gut Microbiota Composition in Irritable Bowel Syndrome Without Constipation: Results from a Double-Blind, Randomized, Placebo-Controlled Trial 61
Therapeutic Role of Probiotics for the Treatment of Dyspepsia: A Review of the Literature 48
Psychological and Clinical Factors Mediate Post-COVID-19 Irritable Bowel Syndrome 47
Totale 10.677
Categoria #
all - tutte 28.460
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.460


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021114 0 0 0 0 0 0 0 0 0 0 0 114
2021/2022882 70 44 17 36 75 47 44 44 53 24 325 103
2022/20231.053 79 216 75 83 79 84 34 91 157 24 67 64
2023/2024594 21 60 40 57 70 69 23 30 30 86 64 44
2024/20252.109 116 266 190 203 275 104 148 127 75 140 158 307
2025/20264.483 310 381 332 338 361 219 637 190 839 307 237 332
Totale 10.677